Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Biochemical and Biophysical Research Communications|April 7, 2019
Inhibition of a pancreatic cancer model by cooperative pairs of clinically approved and experimental antibodiesRuth Maron, Bilha Schechter, Nishanth Belugali Nataraj, et al.
Veterinary Pathology|November 3, 2023
PDL1 immunohistochemistry in canine neoplasms: Validation of commercial antibodies, standardization of evaluation, and scoring systemsLuisa Vera Muscatello, Francesca Gobbo, Giancarlo Avallone, et al.
Frontiers in Oncology|June 6, 2022
Neuregulin 4 Boosts the Efficacy of Anti-ERBB2 Neutralizing AntibodiesCarmen Miano, Donatella Romaniello, Martina Mazzeschi, et al.
Oncotarget|May 11, 2017
Analysis of STAT3 post-translational modifications (PTMs) in human prostate cancer with different Gleason ScoreRossana Cocchiola, Donatella Romaniello, Caterina Grillo, et al.
Biomedicines|September 23, 2022
β-Caryophyllene Counteracts Chemoresistance Induced by Cigarette Smoke in Triple-Negative Breast Cancer MDA-MB-468 CellsAntonella Di Sotto, Marco Gullì, Marco Minacori, et al.
International Journal of Molecular Sciences|April 25, 2019
STAT3 Post-Translational Modifications Drive Cellular Signaling Pathways in Prostate Cancer CellsRossana Cocchiola, Elisabetta Rubini, Fabio Altieri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2018
A Combination of Approved Antibodies Overcomes Resistance of Lung Cancer to Osimertinib by Blocking Bypass PathwaysDonatella Romaniello, Luigi Mazzeo, Maicol Mancini, et al.
Cancers|April 12, 2022
NRG1/ERBB3/ERBB2 Axis Triggers Anchorage-Independent Growth of Basal-like/Triple-Negative Breast Cancer CellsCarmen Miano, Alessandra Morselli, Francesca Pontis, et al.
EMBO Molecular Medicine|March 4, 2021
Upfront admixing antibodies and EGFR inhibitors preempts sequential treatments in lung cancer modelsIlaria Marrocco, Donatella Romaniello, Itay Vaknin, et al.
Critical Reviews in Oncology/Hematology|February 14, 2026
Beyond EGFR inhibition in Head and Neck Squamous Cell Carcinoma: overcoming resistance mechanisms and novel therapeutic frontiersFrancesca Carosi, Daria Maria Filippini, Laura Fabbri, et al.
Pageof 4